Cart
sales@molnova.com
Azilsartan Methyl Ester
CAS No. 147403-52-9
Azilsartan Methyl Ester( —— )
Catalog No. M35894 CAS No. 147403-52-9
Azilsartan Methyl Ester is an angiotensin II receptor antagonist. Azilsartan Methyl Ester inhibits specific binding of [125I]AII (0.2 nM) to bovine adrenal cortex with IC50 value is 0.44uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 34 | In Stock |
|
| 100MG | 50 | In Stock |
|
| 500MG | 143 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAzilsartan Methyl Ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionAzilsartan Methyl Ester is an angiotensin II receptor antagonist. Azilsartan Methyl Ester inhibits specific binding of [125I]AII (0.2 nM) to bovine adrenal cortex with IC50 value is 0.44uM.
-
DescriptionAzilsartan methyl ester, a derivative of Azilsartan (HY-14914), is an angiotensin II receptor antagonist that plays an important role in hypertension.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorRAAS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number147403-52-9
-
Formula Weight470.48
-
Molecular FormulaC26H22N4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOc1nc2cccc(C(=O)OC)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Alison Handley, et al. Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study. Clin Exp Hypertens. 2016;38(2):180-8.
molnova catalog
related products
-
Terlakiren
Terlakiren (CP-80,794) is an orally active, potent renin inhibitor used in the study of neurological disorders related to hypertension.
-
Trans-Tranilast
Trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
-
Buloxibutid
Buloxibutid (AT2 receptor agonist C21) is a novel and selective small molecule angiotensin II AT2 receptor agonist, exhibiting Ki values of 0.4 nM and 10 μM for AT2 and AT1 receptors, respectively.
